US regulators on Friday allowed emergency use of the first drug that appears to help some Covid-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus.The Food and Drug Administration cleared Gilead Science's intravenous drug for hospitalized patients with "severe disease," such as those experiencing breathing problems requiring supplemental oxygen or ventilators.Friday, 1 May 2020
US regulators on Friday allowed emergency use of the first drug that appears to help some Covid-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus.The Food and Drug Administration cleared Gilead Science's intravenous drug for hospitalized patients with "severe disease," such as those experiencing breathing problems requiring supplemental oxygen or ventilators.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment